For this, we compared three different cell lines: ductal breast carcinoma in situ that are considered control tumor cells and two derivative cell lines obtained by inactivation of either NME1 or its closely related isoform NME2. This evidence concerns the gene NME2 and ductal breast carcinoma in situ.